Jurij Hanžel

39PUBLICATIONS
103CO-AUTHORS
Infant and child healthMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Central and Eastern European languages (incl. Russian)Agricultural molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Oct 31, 2026
Prevalence and epidemiologic features of adult upper gastrointestinal Crohn's disease over the last 30 years: a scoping review.

|May 30, 2026
Biologics and small molecules for perianal Crohn's disease: a systematic review and meta-analyses of randomized placebo-controlled trials.

|Mar 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis.

Emmanuel Niyigena, Yannick Hoffert, Waqqas Afif

|Dec 01, 2025
An evaluation of guselkumab for the treatment of ulcerative colitis.

Jurij Hanzel, Vipul Jairath, Brian G Feagan

|Aug 06, 2024
Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease.

Florian Rieder, Christopher Ma, Jurij Hanzel

|Jul 01, 2024
Differences Between the 2016 and 2022 Food and Drug Administration Guidance-Implications for Design and Interpretation of Clinical Trials in Ulcerative Colitis.

Jurij Hanzel, Christopher Ma, Laurent Peyrin-Biroulet

Pageof 7

Frequent Collaborators

15 joint publications

Christopher Ma

9 joint publications

Vipul Jairath

6 joint publications

David Drobne

6 joint publications

Peter Bossuyt